Table 7.
Parameters | Initial findings (admission day) | Post-COVID-19 4-week follow-up | ||||
---|---|---|---|---|---|---|
Patients (n) | Male | Female | Patients | Male | Female | |
Chest X ray | 62 | 55 | 7 | 3 (0.48%) | 2 (3.6%) | 1 (14.2%) |
Decreased Hb | 31 (50%) | 28 (50.9%) | 4 (57.1%) | 26 (41.9%) | 23 (41.8%) | 3 (42.8%) |
Increased ESR | 43 (69.4%) | 39 (70.9%) | 4 (57.1%) | 34 (54.8%) | 30 (54.5%) | 4 (57.1%) |
Leukocytosis | 8 (12.9%) | 6 (10.9%) | 2 (28.6%) | 10 (16.1%) | 9 (16.3%) | 1 (14.2%) |
Decreased RBC | 4 (6.5%) | 0 | 4 (57.1%) | 3 (4.84%) | 0 | 3 (42.8%) |
Platelet | 0 | 0 | 0 | 0 | 0 | 0 |
Neutrophil | ↑11 (17.7%) | ↑10 (18.2%) | ↑1 (14.3%) | ↑4 (33.8%) | ↑4 (7.2%) | 0 |
Lymphocyte | ↓11 (17.7%) | ↓10 (18.2%) | ↓1 (14.3%) | ↑9 (14.5%) | ↑7 (12.7%) | ↑2 (28.6%) |
Monocyte ↑↓ | 0 | 0 | 0 | 0 | 0 | 0 |
Esinophil ↑↓ | 0 | 0 | 0 | 0 | 0 | 0 |
Basophil ↑↓ | 0 | 0 | 0 | 0 | 0 | 0 |
Increased CRP | 62 (100%) | 55 (100%) | 7 (100%) | 11 (17.7%) | 8 (14.5%) | 3 (42.8%) |
Increased SGPT | 18 (29%) | 16 (29%) | 2 (28.6%) | 3 (4.8%) | 3 (5.4%) | 0 |
Increased ferritin | 28 (45.1%) | 25 (45.5%) | 3 (42.9%) | 6 (9.7%) | 5 (9.1%) | 1 (14.2%) |
Increased PT | 14 (22.6%) | 11 (20%) | 3 (42.9%) | 16 (25.8%) | 13 (23.6%) | 3 (42.8%) |
Increased D-dimer | 31 (50%) | 29 (52.7%) | 2 (28.6%) | 4 (6.4%) | 4 (7.3%) | 0 |
Increased creatinine | 2 (3.2%) | 2 (3.6%) | 0 | 0 | 0 | 0 |
The total number of patients (n = 62); Male: 55, Female: 7. Reference value: Hb (g/dl): Female: 12–16; Male: 14–18; ESR (mm in first hour): Female: 0–15; Male: 0–10; WBC/CC: 4,000–11,000; RBC (Million/CC): 4.0–6.2; Platelet/CC: 150,000–450,000; Neutrophil: 40%−75%; Lymphocyte: 20–45%; Monocyte: 2–10%; Eosinophil: 1–6%; Basophil: 0–1%; CRP (mg/dl): <3; SGPT (Units/L) Male: 16–63 Female: 14–59; Serum ferritin (ng/ml): Male: 13–370, Female: 9–253; PT (s): 0–13. COVID-19, coronavirus disease 2019; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Hb, hemoglobin; PT, prothrombin time; RBC, red blood cell; SGPT, serum glutamic pyruvic transaminase; WBC, white blood cell. ↑increase value, ↓decrease value.